Back to Search
Start Over
An overview of cutaneous T cell lymphomas [version 1; referees: 2 approved]
- Source :
- F1000Research. 5:F1000 Faculty Rev-1882
- Publication Year :
- 2016
- Publisher :
- London, UK: F1000 Research Limited, 2016.
-
Abstract
- Cutaneous T cell lymphomas (CTCLs) are a heterogeneous group of extranodal non-Hodgkin’s lymphomas that are characterized by a cutaneous infiltration of malignant monoclonal T lymphocytes. They typically afflict adults with a median age of 55 to 60 years, and the annual incidence is about 0.5 per 100,000. Mycosis fungoides, Sézary syndrome, and primary cutaneous peripheral T cell lymphomas not otherwise specified are the most important subtypes of CTCL. CTCL is a complicated concept in terms of etiopathogenesis, diagnosis, therapy, and prognosis. Herein, we summarize advances which have been achieved in these fields.
- Subjects :
- Review
Articles
Cell Growth & Division
Cell Signaling
Cellular Death & Stress Responses
Control of Gene Expression
Cutaneous Signs of Systemic Disease
Developmental Molecular Mechanisms
Genetics of the Immune System
Immunopharmacology & Hematologic Pharmacology
Leukocyte Signaling & Gene Expression
Lymphomas & Myelomas
Medical Genetics
Photodermatology & Skin Aging
Stem Cells & Regeneration
cutaneous T cell lymphoma
mycosis fungoides
Sézary syndrome
Subjects
Details
- ISSN :
- 20461402
- Volume :
- 5
- Database :
- F1000Research
- Journal :
- F1000Research
- Notes :
- Editorial Note on the Review Process F1000 Faculty Reviews are commissioned from members of the prestigious F1000 Faculty and are edited as a service to readers. In order to make these reviews as comprehensive and accessible as possible, the referees provide input before publication and only the final, revised version is published. The referees who approved the final version are listed with their names and affiliations but without their reports on earlier versions (any comments will already have been addressed in the published version). The referees who approved this article are: Stefano Pileri, Unit of Haematopathology, European Institute of Oncology, Milan/Bologna University School of Medicine, Bologna, Italy No competing interests were disclosed. Mary Jo Lechowicz, Department of Hematology Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA No competing interests were disclosed., , [version 1; referees: 2 approved]
- Publication Type :
- Academic Journal
- Accession number :
- edsfor.10.12688.f1000research.8829.1
- Document Type :
- review
- Full Text :
- https://doi.org/10.12688/f1000research.8829.1